SHANGHAI, July 13 (Reuters) - Drugmaker China Medical System will pay Insilico Medicine up to about 1.2 billion yuan ($177 million) in milestone payments for a research and development programme in ...

Chronic constipation is a common digestive disorder and is often viewed as a trivial problem across the world but now ...

Advancing a pipeline of in vivo CAR-T product candidates for oncology and immunology applications differentiated by ...

Learn the early Parkinson's disease symptoms to watch for, from tremors to sleep changes, and why early recognition matters.

SciSparc Ltd. (Nasdaq: SPRC) ('Company” or 'SciSparc”), today announced that its subsidiary NeuroThera Labs Inc. (TSXV: NTLX) ('NeuroThera'), a clinical-stage pharmaceutical company focused on ...

Cachexia is a condition in which patients affected by cancer or other chronic diseases become sick and lose weight.

Brain & Behavior Research Foundation Honors Six Early-Career Scientists with 2026 Klerman & Freedman Prizes for Mental Health Research ...

The developer of a drug for the rare multiple system atrophy, Alterity will launch a pivotal phase III trial after a go-ahead ...

On Thursday, the Christopher Columbus High School alum came back to Miami to personally deliver the $500,000 check he ...

"She was the love of my life. We were together — willingly — for 36 years." ...

Study examines Qalsody safety after approval “This study is the first to systematically conduct a post-marketing [safety] ...

NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a company developing advanced artificial intelligence solutions for clinical trial optimization and ...